Plant photosynthesis tested as a cardiac energy aid
Researchers in China have adapted part of spinach’s photosynthetic machinery for an unusual medical experiment: helping damaged rat hearts produce more usable energy. The study, led by researchers at Union Hospital of Huazhong University of Science and Technology in Wuhan and reported in Small, describes nanoparticles made from plant thylakoid membranes and activated by red light.
The early-stage work is aimed at a central problem in heart failure. Heart muscle requires a continual supply of ATP, the molecule cells use to power essential work. When the mitochondria that normally provide much of that ATP are impaired, an energy shortage can compound the heart’s difficulty pumping blood.
Plants also produce ATP, but through photosynthesis. The researchers extracted thylakoid membranes from spinach, broke them into nanoscale particles and sought to turn that plant system into a controllable energy source for cardiac cells. Their results in cell experiments and rats suggest the approach can raise ATP levels under red-light stimulation and may reduce injury in an experimental heart-failure setting.
How the particles were designed
Thylakoids are membrane structures within plant cells that contain the machinery used to convert light into chemical energy. Rather than administering the raw plant material, the team packaged the thylakoid-derived nanoparticles in membranes taken from heart muscle cells. The coating was intended to improve the particles’ interaction with cardiomyocytes, the cells responsible for the heart’s contractions.
In laboratory tests, cultured rat heart cells took up more of the coated particles than uncoated particles. When the cells were exposed to red light, the treated cells showed higher ATP levels. The researchers characterize the resulting platform as a light-controlled nano-photosynthetic system, effectively using plant-derived machinery as a biological energy source.
That control is an important feature of the concept. The particles are not described as a replacement for the heart’s natural metabolism. Instead, red light provides the trigger for the added energy-producing activity. In principle, that could allow a future treatment to be switched on at selected times, although the reported work is far from establishing whether such control would be safe or practical in people.
What happened in rats
The team tested the system in rats with experimentally induced heart failure. According to the report, animals receiving the spinach-derived, heart-cell-membrane-coated nanoparticles with red-light activation showed improved pumping function and less tissue damage than comparison animals in the experiment.
The finding is notable because it targets a mechanism beneath many visible features of heart failure: the gap between the energy the heart needs and the energy its compromised cells can generate. Much of cardiovascular treatment focuses on reducing workload, managing fluid balance or addressing the underlying disease process. This study explores whether supplying an additional, light-driven source of cellular energy could eventually complement such strategies.
The researchers’ framing remains appropriately experimental. The result demonstrates an effect in rat cells and a rat disease model, not an established therapy. It does not show that spinach nanoparticles can treat heart failure in people, nor does it establish the long-term safety of introducing plant-derived nanomaterials or repeatedly illuminating tissue.
A promising result with substantial translational questions
Several questions would need answers before this type of technology could move beyond preclinical research. Scientists would need to determine how the particles distribute through the body, how long they remain active, whether they provoke immune reactions and whether the light dose required can reach target tissue safely. Researchers would also need to assess whether the added ATP production produces durable benefits across different causes and stages of heart failure.
Delivery is another practical challenge. A therapy that depends on red-light stimulation must pair its biological treatment with a reliable method of exposing the relevant tissue to light. The study shows that this activation can work in the reported experimental setup; it does not resolve how a comparable system would be used in routine clinical care.
Still, the research illustrates a broader direction in nanomedicine: borrowing biological functions from one organism and adapting them for another. Here, the borrowed function is photosynthetic energy conversion, paired with a cell-membrane coating intended to guide the material toward cardiac cells.
- The particles were derived from spinach thylakoid membranes.
- Heart-muscle-cell membranes were used as a coating to improve uptake by cardiomyocytes in laboratory tests.
- Red-light activation was associated with higher ATP levels in treated rat heart cells.
- In rats with induced heart failure, the reported treatment was associated with improved pumping function and reduced tissue damage.
The significance is in the proof of concept
The study should be read as a proof of concept rather than a near-term treatment. Its value lies in showing that plant photosynthetic components can be engineered into a nanoscale system, brought into heart cells and activated with light in an animal model. That is a striking technical demonstration, especially for a disease defined in part by impaired cellular energy handling.
Whether the method becomes medically useful will depend on results that have not yet been reported: replication, longer follow-up, safety testing and work in models that more closely reflect human disease. For now, the findings offer an inventive answer to a basic biological question—whether some of a leaf’s energy-making machinery can be redirected to a struggling heart. In rats, under controlled conditions, the researchers report that it can.
This article is based on reporting by Phys.org. Read the original article.
Originally published on phys.org
